Ropivacaine Epidural Injection Effective in Posterior Lumbar Interbody Spinal Arthrodesis .
This report has been verified
by one or more authors of the
original publication.
Early Postoperative Analgesic Effects of a Single Epidural Injection of Ropivacaine Administered Preoperatively in Posterior Lumbar Interbody Spinal Arthrodesis: A Pilot Randomized Controlled Trial
J Bone Joint Surg Am. 2013 Mar 6;95(5):393-39960 patients undergoing planned one-level posterior lumbar interbody arthrodesis were randomized to study the analgesic effectiveness of a single epidural injection of ropivacaine. Patients received either a 10-mL epidural injection of 0.1% ropivacaine 20 minutes before the skin incision or a control epidural injection of 10 mL of 0.9% saline solution. Outcomes were assessed of the first 48 hours postoperatively and at discharge. Ropivacaine injection provided better early postoperative analgesia and decreased fentanyl consumption within 12 hours, without related complications such as transient motor weakness.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
